Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CY.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBB.3.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBTNHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BQ.1.1.12NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BQ.1.33NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBB.1.29NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.5.1.28NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CL.1.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BM.1.1.4NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBMNHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BF.34NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CB.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BR.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBB.1.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CL.1.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBB.2.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CH.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
EF.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BR.4NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BN.1.2.5NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CP.4NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.160.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBB.2.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BE.4.1.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
A.2.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.256NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.26NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.177.77NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.34NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.248NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.32NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.70NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.43NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.559NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.14NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.406NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.69NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
A.26NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
ER.1.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CH.1.1.23NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.640NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.1.1.9NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.1.1.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
AY.43.6 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBF.4NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.2.27NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
AY.43.9 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XUNHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.3 (Omicron)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.3.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used